Charlotte Kirby Charlotte Kirby

Chairman hails transformational year for Arecor

Cambridge’s AIM-quoted biopharma group Arecor Therapeutics saw its share price shoot 13p (3.45 per cent) higher to 393p after non-exec chair Dr Andy Richards delivered an upbeat pre-AGM statement.

Read More
Charlotte Kirby Charlotte Kirby

Dogtooth takes robots to Downing Street

Strawberry-harvesting-robot manufacturer Dogtooth Technologies stressed UK growers’ urgent need for labour when it showed its intelligent machines to Boris Johnson

Read More
Charlotte Kirby Charlotte Kirby

Creatd Announces Entry into Print Publishing; Partners with Unbound to Publish First Book of Vocal Stories

Creatd, Inc., a creator-first holding company and the parent company of Vocal, today announced that Creatd Studios, its transmedia production arm, will bring Vocal creators from the digital realm to bookshelves, beginning with the upcoming release of a fiction anthology featuring original stories sourced from Vocal creators. The book will be published in partnership with Unbound, hailed as the world's first crowdfunded publisher.

Read More
Charlotte Kirby Charlotte Kirby

Transformative year for sparkling Arecor

Stockmarket adventurers mining for gold nuggets don’t have to wear illuminated helmets to unearth the value in Cambridge diabetes doyen Arecor Therapeutics.

Read More
Charlotte Kirby Charlotte Kirby

CRFS advances tech capability for civilian and military clients

CRFS, a global leader in RF spectrum monitoring, intelligence, and geolocation solutions, has completed a new phase of research and development into real-time passive 3DTDOA geolocation techniques to pinpoint airborne platforms over many hundreds of kilometres. Having an accurate airspace picture is critical for both civilian and military users.

Read More
Charlotte Kirby Charlotte Kirby

Featurespace and Monavate in FinTech alliance

Cambridge-born and based technology companies Featurespace and Monavate have partnered to embed the former’s world-leading fraud solution ARIC Risk Hub in full-service issuing platform Monavate One.

Read More
Charlotte Kirby Charlotte Kirby

Axol Bioscience raises £3.2 million GBP

Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, announces that it has raised £3.2 million GBP (circa $4.2 million USD) in the extension of its previous funding round, bringing the total raised to £7 million GBP (circa $9.2 million USD).

Read More